President Trump announced last fall that his administration reached agreements with drug manufacturers Novo Nordisk and Eli Lilly on lowering the price of certain obesity drugs on the TrumpRx online platform that launches this month
The result is a reduction in caloric intake driven by biology rather than willpower alone
however, its therapeutic effects eventually wear off and can even cause motor complications, such as fluctuations and dyskinesias
10.1016/j.numecd.2019.07.012 31
All content provided in this blog, website, or any linked materials, including text, graphics, images, patient profiles, outcomes, and information, are not intended and should not be considered or used as a substitute for medical advice, diagnosis, or treatment
Formulary placement for that premium product is easier to defend to employers and plan sponsors when the differentiation is quantified in clinical terms